Interim Vice-President, University of Toronto and Principal, University of Toronto MississaugaUlrich Krull is a professor of analytical chemistry at the University of Toronto, Mississauga Campus, and he holds the AstraZeneca Chair in Biotechnology. His research work explores biosensor and bioassay development, with focus on molecular diagnostics technology for biomedical and environmental applications.
His research team is exploring the use of nanoscale materials and microfluidics technologies to build methods for detection of DNA and RNA targets, and the work includes implementation of nanotechnology for real-time intracellular determination of genetic expression and for concurrent delivery of biologically active molecules. A number of technologies have moved towards commercialization, and work by his research team has been fundamental in the support of 4 start-up companies. His research has produced over 200 refereed publications, 60 book chapters and conference proceedings, and a dozen patents.
A Fellow of the Chemical Institute of Canada, he has received the McBryde Medal, and the Maxxam Award of the Canadian Society for Chemistry for analytical chemistry research. He has been a recipient of the University of Toronto Faculty Excellence Award and a Teaching Excellence Award. He has served the University of Toronto in numerous senior administrative portfolios, on Advisory Boards for industry, and on Boards of organizations that support acceleration of commercialization opportunities.